Clinical Trial

JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma

Name: JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma — clinical trial record (NCT07081022)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the preliminary efficacy of JS203 combined with standard regimens in patients with B-cell Non-Hodgkin's lymphoma

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-15.

Status change: Not Yet Recruiting → Recruiting 2025-08-20

Trial Details

NCT Number	NCT07081022
Lead Sponsor	Shanghai Junshi Bioscience Co., Ltd.
Conditions	B-cell Non-Hodgkin's Lymphoma
Enrollment	180 participants
Start Date	2025-08-17
Primary Completion	2027-04-06 (estimated)
Study Completion	2027-04-06 (estimated)
Updated on ClinicalTrials.gov	2025-08-21